+948.4%
MRNA vs GEN
+166.5%
+781.9%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | GEN | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -3.2% | +1.0% | -1.4% |
| 7D | -12.7% | -3.6% | -9.1% | -12.0% |
| 30D | -20.7% | +21.5% | -42.2% | -24.7% |
| 3M | +46.3% | +4.0% | +42.3% | +43.2% |
| 6M | +305.2% | +17.8% | +287.5% | +280.1% |
| YTD | +561.2% | +9.4% | +551.8% | +526.8% |
| 1Y | +772.1% | +14.2% | +757.9% | +716.6% |
| 3Y | +147.0% | +48.6% | +98.4% | +115.4% |
| 5Y | -26.1% | +29.4% | -55.5% | -34.5% |
| All | +948.4% | +166.5% | +781.9% | +645.4% |
Cumulative growth
Daily Returns
Daily percentage return beside GEN.
Daily Out/Under-Performance
Portfolio return minus GEN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GEN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded GEN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling